Prescribing during pregnancy.  Prenatal drug exposure and an untreated psychiatric disorder both present risks.
D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage* / Q000627:therapeutic use; D018692:Antimanic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D016642:Bupropion / Q000008:administration & dosage* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology*; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000008:administration & dosage* / Q000627:therapeutic use; D011247:Pregnancy; D011295:Prenatal Care / Q000706:statistics & numerical data*; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology*; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D028761:Withholding Treatment / Q000706:statistics & numerical data*
D000929:Antidepressive Agents, Tricyclic; D018692:Antimanic Agents; D016642:Bupropion; D018765:Dopamine Uptake Inhibitors; D018020:Lithium Compounds; D017367:Selective Serotonin Reuptake Inhibitors